- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Champions Oncology Inc (CSBR)
Champions Oncology Inc stock price live, this page displays NASDAQ CSBR stock exchange data. View the CSBR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Champions Oncology Inc real time stock price chart below.
What Is the Champions Oncology Inc Stock Price Today?
The Champions Oncology Inc stock price today is 6.110.
What Is the Stock Symbol for Champions Oncology Inc?
The stock symbol for Champions Oncology Inc is ""CSBR.""
What Stock Exchange Does Champions Oncology Inc Trade On?
Champions Oncology Inc is listed and trades on the NASDAQ stock exchange.
Is Champions Oncology Inc a Good Stock to Buy?
Determining whether Champions Oncology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSBR quote. (ISIN: US15870P3073)
What Is the Champions Oncology Inc Stock Price Today?
The Champions Oncology Inc stock price today is 6.110.
What Is the Stock Symbol for Champions Oncology Inc?
The stock symbol for Champions Oncology Inc is ""CSBR.""
What Stock Exchange Does Champions Oncology Inc Trade On?
Champions Oncology Inc is listed and trades on the NASDAQ stock exchange.
Is Champions Oncology Inc a Good Stock to Buy?
Determining whether Champions Oncology Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSBR quote. (ISIN: US15870P3073)
NASDAQ
Currency in USD
6.110
-0.440(-6.72%)
Closed·
After Hours
6.320+0.210(+3.44%)
·
Fair Value
An estimate of a Champions Oncology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.070
6.510
52 wk Range
3.600
11.990
CSBR Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
CSBR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Champions Oncology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.0706.510
52 wk Range
3.60011.990
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CSBR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Champions Oncology's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
12.000
Upside
+96.40%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
- Champions Oncology names Rob Brainin as new CEO
- Investing.com
- Champions Oncology names Rob Brainin as new CEO
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Champions Oncology Inc Company Profile
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Champions Oncology Inc Earnings Call Summary for Q3/2025
- Champions Oncology reported Q1 2025 EPS of $0.36, beating -$0.01 forecast, with record revenue of $17M vs $12.93M expected
- Company achieved 22% YTD revenue growth to $45M, driven by research services and data revenue streams
- Despite positive earnings, stock fell 2.96% in aftermarket trading to $9.50, possibly due to profit-taking
- Management reaffirmed full-year revenue growth guidance of 10-15%, focusing on data business expansion
- CEO highlighted transformative quarter, positioning company as leader in evolving biotech landscape
Last Updated: 11/03/2025, 23:36
Read Full TranscriptCompare CSBR to Peers and Sector
Metrics to compare | CSBR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSBRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.2x | −0.1x | −0.5x | |
PEG Ratio | 0.12 | 0.11 | 0.00 | |
Price/Book | 23.9x | 1.2x | 2.6x | |
Price / LTM Sales | 1.6x | 1.6x | 3.3x | |
Upside (Analyst Target) | 83.2% | 146.3% | 43.4% | |
Fair Value Upside | Unlock | 29.6% | 7.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.000
(+96.40% Upside)
Earnings
Latest Release
Jul 23, 2025
EPS / Forecast
-0.07 / 0.06
Revenue / Forecast
12.36M / 15.70M
People Also Watch
FAQ
What Stock Exchange Does Champions Oncology Trade On?
Champions Oncology is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Champions Oncology?
The stock symbol for Champions Oncology is "CSBR."
What Is the Champions Oncology Market Cap?
As of today, Champions Oncology market cap is 84.04M.
What Is Champions Oncology's Earnings Per Share (TTM)?
The Champions Oncology EPS (TTM) is 0.34.
When Is the Next Champions Oncology Earnings Date?
Champions Oncology will release its next earnings report on 09 Sept 2025.
From a Technical Analysis Perspective, Is CSBR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Champions Oncology Stock Split?
Champions Oncology has split 2 times.
How Many Employees Does Champions Oncology Have?
Champions Oncology has 213 employees.
What is the current trading status of Champions Oncology (CSBR)?
As of 08 Aug 2025, Champions Oncology (CSBR) is trading at a price of 6.11, with a previous close of 6.55. The stock has fluctuated within a day range of 6.07 to 6.51, while its 52-week range spans from 3.60 to 11.99.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.